- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05536518
Evaluating the Feasibility, Health and Behavioral Impact of Mid-Ohio Farmacy + WW
The aim of this research is to undertake a feasibility study to assess uptake and impact of providing access to a widely available weight management and wellness program (WW; formerly known as Weight Watchers) among individuals experiencing food insecurity and overweight/obesity, who are eligible to receive weekly produce at the Mid-Ohio Food Collective (MOFC) through their pre-existing enrollment in the Mid-Ohio Farmacy program. Participants (n=90) adults over the age of 18 with a BMI between 27-50 kg/m2 will be recruited for a 6 month single-arm clinical trial, where participants will be provided with WW Unlimited Workshop + Digital. The primary objective is to test the feasibility and acceptability of a commercial weight loss and wellness program with an established produce prescription program among individuals experiencing food insecurity and overweight/obesity. Secondary outcomes will include assessments related to weight, height, blood pressure, dietary intake, physical activity, food access, depression, wellbeing and economic factors.
This feasibility study will help inform future interventions among this population. More specifically, this study will help answer questions about the feasibility and acceptability of such an intervention, adherence to the WW program as described to the participant, and the impact that access to a free weight management and wellness program can have on health-related outcomes among individuals experiencing food insecurity and overweight/obesity.
Study Overview
Status
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Grove City, Ohio, United States, 43123
- Mid-Ohio Food Collective
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 year or older
- BMI 27-50 kg/m2
- Positive screen for food insecurity at healthcare provider
- Enrolled in Mid-Ohio Farmacy (produce prescription program)
- Speak English
- Live in greater Columbus,Ohio area for duration of study
- Reliable internet access
- Ability to download and install WW app on phone
Exclusion Criteria:
- Participation in a structured weight loss program in the last 12 months
- WW membership in the last 12 months
- Pregnant, nursing or planning to become pregnant
- Weight loss of 5kg or more in the past 6 months
- Taking prescription medications for weight loss
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Mid-Ohio Farmacy (produce prescription) + WW International Coaching (In person and/or Virtual)
|
All study participants are members of the Mid-Ohio Farmacy produce prescription program.
All participants are food insecure and will be enrolled and participate in WW coaching sessions for 24 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total number of patients excluded (Feasibility and Acceptability)
Time Frame: Up to 8 months
|
Total number of patients excluded from participation in the intervention
|
Up to 8 months
|
|
Adherence to study activities (Feasibility and Acceptability)
Time Frame: Up to 8 months
|
Percent of study activities completed by each patient
|
Up to 8 months
|
|
Attrition rate (Feasibility and Acceptability)
Time Frame: Up to 8 months
|
Attrition rate (rate at which patients withdraw from the intervention)
|
Up to 8 months
|
|
Participant Satisfaction with the program (Feasibility and Acceptability)
Time Frame: Up to 8 months
|
Participant satisfaction with the intervention (Participant satisfaction questionnaires and semi-structured focus groups)
|
Up to 8 months
|
|
Food pantry visits (Feasibility and Acceptability)
Time Frame: Up to 8 months
|
Total number of food pantry visits prior to and following enrollment in the intervention
|
Up to 8 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in body weight (Clinical Outcomes)
Time Frame: Up to 8 months
|
Change in body weight (lbs) from the beginning to the end of the intervention
|
Up to 8 months
|
|
Change in body mass index (BMI) (Clinical Outcomes)
Time Frame: Up to 8 months
|
Change in BMI (weight (lb) / [height (in)]2 x 703) from the beginning to the end of the intervention.
|
Up to 8 months
|
|
Change in blood pressure (Clinical Outcomes)
Time Frame: Up to 8 months
|
Change in blood pressure (mmHg) from the beginning to the end of the intervention.
|
Up to 8 months
|
|
Change in physical activity (Clinical Outcomes)
Time Frame: Up to 8 months
|
Change in physical activity (hours/minutes of activity) from the beginning to the end of the intervention.
|
Up to 8 months
|
|
Change in dietary intake (Clinical Outcomes)
Time Frame: Up to 8 months
|
Change in frequency of consumption of fruits/vegetables, whole grain foods and low fat dairy/dairy alternatives from the beginning to the end of the intervention.
|
Up to 8 months
|
|
Change in food security status (SDOH Outcomes)
Time Frame: Up to 8 months
|
Change in food security status from the beginning to the end of the intervention (food secure vs. food insecure)
|
Up to 8 months
|
|
Change in economic trade-offs (SDOH Outcomes)
Time Frame: Up to 8 months
|
Change in economic trade-offs (choices made between purchasing food and other necessities) from the beginning to the end of the intervention
|
Up to 8 months
|
|
Change in health related quality of life (SDOH Outcomes)
Time Frame: Up to 8 months
|
Change in health related quality of life using the CDC Health Related Quality of Life Healthy Days Core Module (HRQOL-4) from the beginning to the end of the intervention
|
Up to 8 months
|
|
Change in well-being (SDOH Outcomes)
Time Frame: Up to 8 months
|
Change in well-being using the World Health Organisation-5 Well Being Index (WHO-5) from the beginning to the end of the intervention.
|
Up to 8 months
|
|
Change in depression (SDOH Outcomes)
Time Frame: Up to 8 months
|
Change in depression using the Patient Health Questionnaire-2 (PHQ-2) from the beginning to the end of the intervention.
|
Up to 8 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20222251
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.